Vassilios Gregoriou - 12 Jul 2022 Form 4 Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Role
CEO, Chair, Director, 10%+ Owner
Signature
/s/ Vassilios Gregoriou
Issuer symbol
ADN
Transactions as of
12 Jul 2022
Net transactions value
$0
Form type
4
Filing time
15 Jul 2022, 17:53:33 UTC
Previous filing
26 Aug 2022
Next filing
07 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADN Common Stock Award $0 +175,000 +2.7% $0.000000 6,562,624 12 Jul 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADN Employee Stock Options (right to buy) Award $0 +175,000 $0.000000 175,000 12 Jul 2022 Common Stock 175,000 $2.74 Direct F3, F4
holding ADN Employee Stock Options (right to buy) 922,118 12 Jul 2022 Common Stock 922,118 $10.36 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs"), representing a contingent right to receive common stock, granted pursuant to Issuer's 2021 Equity Incentive Plan, dated February 4, 2021 (the "Plan").
F2 RSUs are a common stock equivalent that may be settled solely by delivery of an equal number of shares of Issuer's common stock. They vest 25% over four years on each anniversary of the grant date and will be fully vested on July 12, 2026.
F3 Employee stock options (right to buy) ("Options") granted pursuant to the Plan.
F4 Options vest 25% over four years on each anniversary of the grant date and will be fully vested as of July 12, 2026.